COVID-19 vaccines efficacy debate worries Australia’s chief medical officer
Jan 16 2021
The EU has sealed six vaccine contracts for up to 2 billion doses, many more than are necessary to cover its population of approximately 450 million.
EMA revealed that the COVID-19 vaccine data stolen in December was leaked online in a previous update, on Tuesday.
Turner said the government must pivot towards getting more of the Moderna and Pfizer vaccines.
Ms Cooke also said she hopes Johnson & Johnson will seek European Union approval for its jab next month.
"We will need more vaccines to cover the needs, not only for Europeans, but for all global citizens who are suffering as a result of this pandemic", she said.
It comes as the government races to strike new COVID-19 vaccine deals as it stares down criticism of the effectiveness of the AstraZeneca jab.
In addition to these drugs, the Australian authorities expected to receive their own vaccine against coronavirus, which was developed by the University of Queensland and the biotechnology company CSL.
"So there's still a lot of work to do to really be able to say definitively whether this will work or not".
In a statement, the ASI said Turner was speaking as an expert in immunology and that the body did not advocate a pause to the rollout as widely reported by local media.
"Production of vaccine is 3-4 month process".
AstraZeneca's vaccine has been approved in countries including Argentina, Britain, El Salvador and India. "It will be available as soon as the TGA gives its tick, which we expect will be in February".
Vaccinations in Australia are set to begin in mid-February with the rollout to be accompanied by a public information campaign on the safety of vaccines.
Its success is largely attributable to closed borders and widespread compliance with social-distancing rules, along with aggressive testing and tracing programmes.
The Labour life peer said there are grounds to show the decision taken by ministers to delay the second dose by up to 12 weeks is unlawful and breaches the conditions of its authorisation - including patients' "legitimate expectations", with them consenting to a course of medical treatment on the understanding they would get a second dose after 21 days.
However, the head of the Oxford Vaccine Group, Andrew Pollard, has come forward and warned that delaying the AstraZeneca vaccine means Australia won't be able to protect people as early as possible.
Mr Kelly said the "choice is not whether one is better than the other", when it came to rolling out a vaccine.
In Queensland, hundreds of hotel quarantine guests were forced to restart their isolation after a handful of cases in the facility were linked to the highly contagious United Kingdom virus strain.